X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (588) 588
Publication (45) 45
Book Chapter (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (430) 430
oncology (371) 371
radiotherapy (344) 344
index medicus (334) 334
female (303) 303
male (287) 287
aged (278) 278
middle aged (278) 278
chemotherapy (240) 240
adult (220) 220
cancer (203) 203
radiation-therapy (194) 194
glioblastoma (161) 161
treatment outcome (158) 158
concomitant radiochemotherapy (146) 146
concomitant (145) 145
adjuvant temozolomide (144) 144
combined modality therapy (141) 141
radiology, nuclear medicine & medical imaging (131) 131
surgery (131) 131
care and treatment (127) 127
survival (126) 126
prognosis (118) 118
squamous-cell carcinoma (117) 117
temozolomide (117) 117
medicine & public health (116) 116
retrospective studies (115) 115
glioblastoma multiforme (110) 110
clinical neurology (106) 106
aged, 80 and over (103) 103
chemoradiotherapy (96) 96
radiation therapy (88) 88
radiation (86) 86
neoplasm staging (85) 85
disease-free survival (84) 84
head and neck cancer (82) 82
locally advanced head (80) 80
dacarbazine - analogs & derivatives (79) 79
malignant glioma (76) 76
survival rate (75) 75
brain neoplasms - therapy (74) 74
cisplatin (73) 73
research (73) 73
antineoplastic combined chemotherapy protocols - therapeutic use (72) 72
analysis (70) 70
concomitant chemotherapy (68) 68
follow-up studies (68) 68
survival analysis (67) 67
brain neoplasms - mortality (64) 64
head and neck neoplasms - radiotherapy (64) 64
brain neoplasms - pathology (62) 62
carcinoma, squamous cell - pathology (61) 61
radiochemotherapy (61) 61
randomized-trial (61) 61
brain neoplasms - drug therapy (60) 60
tumors (59) 59
carcinoma, squamous cell - radiotherapy (58) 58
concomitant chemoradiotherapy (58) 58
glioblastoma - therapy (57) 57
head and neck neoplasms - drug therapy (57) 57
dacarbazine - therapeutic use (56) 56
gliomas (56) 56
cisplatin - administration & dosage (55) 55
carcinoma, squamous cell - therapy (54) 54
glioblastoma - mortality (54) 54
health aspects (54) 54
multiforme (53) 53
neurology (53) 53
antineoplastic agents - therapeutic use (52) 52
antineoplastic agents, alkylating - therapeutic use (52) 52
brain neoplasms - radiotherapy (51) 51
glioblastoma - pathology (51) 51
magnetic resonance imaging (51) 51
patients (51) 51
radiotherapy dosage (51) 51
squamous cell carcinoma (51) 51
carcinoma, squamous cell - drug therapy (50) 50
newly-diagnosed glioblastoma (49) 49
pseudoprogression (49) 49
toxicity (49) 49
kaplan-meier estimate (48) 48
chemoradiation (47) 47
disease progression (47) 47
glioblastoma - drug therapy (47) 47
dose fractionation (46) 46
patient outcomes (46) 46
head and neck neoplasms - pathology (45) 45
head and neck neoplasms - therapy (45) 45
trial (45) 45
chemotherapy, adjuvant (44) 44
hematology, oncology and palliative medicine (44) 44
high-grade gliomas (44) 44
radiotherapy plus concomitant (44) 44
fluorouracil - administration & dosage (43) 43
glioblastoma - radiotherapy (43) 43
young adult (43) 43
carcinoma (42) 42
phase-ii (42) 42
otorhinolaryngology (41) 41
carcinoma, squamous cell - mortality (40) 40
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (532) 532
French (31) 31
German (11) 11
Polish (5) 5
Czech (3) 3
Italian (3) 3
Korean (2) 2
Spanish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 1, pp. 176 - 184
Purpose Early detection of treatment response in glioma patients after radiochemotherapy (RCX) is uncertain because treatment-related contrast enhancement in... 
Radiology | Hematology, Oncology and Palliative Medicine | Early response | [ 18F]fluoroethyl)-L-tyrosine positron emission tomography | Radiotherapy | Glioblastoma | Radiochemotherapy | F]fluoroethyl)-L-tyrosine positron emission tomography | MGMT PROMOTER METHYLATION | CEREBRAL GLIOMAS | CHEMOTHERAPY | ADJUVANT TEMOZOLOMIDE | RADIATION-THERAPY | BRAIN-TUMORS | MALIGNANT GLIOMA | ONCOLOGY | [F-18]fluoroethyl)-L-tyrosine positron emission tomography | CONFORMAL RADIOTHERAPY | CONCOMITANT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | Prognosis | Prospective Studies | Dacarbazine - therapeutic use | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Male | Tyrosine - analogs & derivatives | Brain Neoplasms - metabolism | Glioblastoma - diagnostic imaging | Dacarbazine - analogs & derivatives | Adult | Female | Glioblastoma - metabolism | Tyrosine - pharmacokinetics | Radiopharmaceuticals - pharmacokinetics | Positron-Emission Tomography - methods | Antineoplastic Agents, Alkylating - therapeutic use | Glioblastoma - therapy | Disease-Free Survival | Magnetic Resonance Imaging | Brain Neoplasms - therapy | Aged | Combined Modality Therapy - methods | Temozolomide | PET imaging | Tracers (Biology) | Gliomas | Radiation | Development and progression | Universities and colleges | TOMOGRAPHY | HOURS LIVING RADIOISOTOPES | EMISSION COMPUTED TOMOGRAPHY | MEDICINE | FLUORINE ISOTOPES | NERVOUS SYSTEM DISEASES | THERAPY | NANOSECONDS LIVING RADIOISOTOPES | TYROSINE | POSITRON COMPUTED TOMOGRAPHY | AMINO ACIDS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | LIGHT NUCLEI | COMBINED THERAPY | GLIOMAS | BETA-PLUS DECAY RADIOISOTOPES | DIAGNOSTIC TECHNIQUES | NEOPLASMS | ISOMERIC TRANSITION ISOTOPES | ORGANIC COMPOUNDS | HYDROXY ACIDS | ORGANIC ACIDS | RADIOISOTOPES | COMPUTERIZED TOMOGRAPHY | ISOTOPES | DISEASES | NUCLEI | UPTAKE | CARBOXYLIC ACIDS | ODD-ODD NUCLEI | FLUORINE 18
Journal Article
International Journal of Cancer, ISSN 0020-7136, 07/2016, Volume 139, Issue 2, pp. 424 - 432
Journal Article
Journal Article
Journal Article
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 12/2017, Volume 193, Issue 12, pp. 1048 - 1055
Journal Article
RADIOTHERAPY AND ONCOLOGY, ISSN 0167-8140, 05/2011, Volume 99, Issue 2, pp. 218 - 224
Background and purpose: Resection is considered as essential for the efficacy of modern adjuvant treatment of glioblastoma multiforme (GBM). Previous studies... 
SURVIVAL | Prognosis | Amino acid PET | [F-18]Fluoroethyl-L-tyrosine | Glioblastoma | VOLUME | Radiotherapy | MULTIFORME | RADIATION-THERAPY | MALIGNANT GLIOMA | POSITRON-EMISSION-TOMOGRAPHY | FET | ONCOLOGY | RADIOTHERAPY PLUS CONCOMITANT | HIGH-GRADE GLIOMAS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | BRAIN
Journal Article
Journal Article
Journal Article